Michael Heslinga is a Principal Scientist at Merck, where they lead the design and development of various small molecule formulations. Prior to their role at Merck, they served as a Senior Scientist at Allergan from 2017 to 2020. Michael gained valuable teaching experience as a Graduate Student Instructor at the University of Michigan and worked as a Teaching Assistant at Calvin College. They earned a Master of Science in Chemical Engineering from the University of Michigan and a Bachelor of Science in Engineering with a focus on Chemical Concentration and Physics from Calvin University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices